To optimize the tumor-targeting properties of the radiolabeled BBN(7–14) moiety, Valverde et al. (2016) improved the metabolic stability and tumor uptake of GRPR-specific via radiolabeling [Nle14]BBN(7–14) derivatives by means of structural modifications of the peptide vector. This evidence concerns the gene GRPR and neoplasm.